Cipla receives final approval for Metoprolol Succinate XR formulation
Cipla Ltd. has announced that it has received final approval for its Abbreviated New Drug Application (ANDA) for Metoprolol ER Tablets 50 mg, 100 mg, 200 mg from the US FDA.
The drug is AB-rated generic therapeutic equivalent version of Aralez Pharmaceuticals, Inc.’s, Toprol XL – beta1-selective adrenoceptor blocking agent. Metoprolol succinate extended-release tablets are indicated for the treatment of hypertension, to lower blood pressure, angina pectoris, heart failure etc. According to IQVIA, Toprol XL and its generic equivalents had US sales of approximately $464-mn for the 12-month period ending August 2018.
You May Interested In
2026-10-04
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
India Launches Concentrated Anti-Dumping Actions Against Eight Categories of Chinese Chemicals, Covering APIs/Intermediates, Polyurethanes, and Refrigerants
-
Three Major Indian Chemical Investments Target China's PC Exports
-
U.S.-Iran Détente Triggers Oil Price Plunge, Energy and Chemical Sectors Tumble
-
"Zipper-Like" Opening and Closing of Hormuz Coupled with Russian Export Ban Send Energy and Chemical Prices Soaring
-
India Launches Anti-Dumping Probe into PET Film from China, Singapore, Thailand and the UAE
-
India Imposes Final Anti‑Dumping Duties on Ethylenediamine from China, EU, Saudi Arabia, and Taiwan, China, with Top Rate of $575/tonne
-
Global Countries Impose Tariffs on Chinese Chemical Products
-
AUTOMA Chem 2026: Powering Industry 4.0 in Chemistry
-
Urea Prices Surge as India Faces Critical Shortages: Will China’s Export Quotas Provide Relief?
-
Chemical Raw Materials: How to Source Quality Suppliers & Understand Grades
Recommend Reading
-
![Production Down 6%, Profits Cut by $3.7 Billion: Middle East Conflict Hits ExxonMobil Hard]()
Production Down 6%, Profits Cut by $3.7 Billion: Middle East Conflict Hits ExxonMobil Hard
-
![Titanium Dioxide: Stuck Between Weak Upside and Limited Downside]()
Titanium Dioxide: Stuck Between Weak Upside and Limited Downside
-
![Shell Plans to Sell U.S. Chemical Assets for Up to $8 Billion, with ExxonMobil and LyondellBasell Joining the Bidding]()
Shell Plans to Sell U.S. Chemical Assets for Up to $8 Billion, with ExxonMobil and LyondellBasell Joining the Bidding
-
![BASF and Clariant Exit Quietly! Behind Henkel’s High-Priced Acquisition, Why Did Former Allies Choose to “Let Go”?]()
BASF and Clariant Exit Quietly! Behind Henkel’s High-Priced Acquisition, Why Did Former Allies Choose to “Let Go”?
-
![BASF and Encina Bet on Circular Chemical Feedstocks]()
BASF and Encina Bet on Circular Chemical Feedstocks
-
![Business Society’s September 20, 2026 Melamine Trend Analysis: Slightly Bearish Fluctuations]()
Business Society’s September 20, 2026 Melamine Trend Analysis: Slightly Bearish Fluctuations
-
![Energy and Chemical Futures Plunge Across the Board; PET Shows Resilience Against Declines]()
Energy and Chemical Futures Plunge Across the Board; PET Shows Resilience Against Declines
-
![This week, caustic soda prices were weak (2.2-2.6)]()
This week, caustic soda prices were weak (2.2-2.6)
-
![Fundamentals Weaken, Adjusting; Polyester Staple Fiber Prices Slightly Decline]()
Fundamentals Weaken, Adjusting; Polyester Staple Fiber Prices Slightly Decline
-
![Business Society’s Trend Analysis for Polyester Staple Fiber on September 18, 2026: Volatile]()
Business Society’s Trend Analysis for Polyester Staple Fiber on September 18, 2026: Volatile
